Tool took a long studio break between their 2006 album 10,000 Days and its follow-up, Fear Inoculum in 2019. Luckily, it appears that the Los Angeles rockers don’t want to do that with their new release.
In a recent chat with Revolver Magazine, bassist Justin Chancellor and drummer Danny Carey discussed Tool’s plans for the future and the possibility of recording new music. According to the duo, the group wants to speed up the process this time.
“Time is precious now, so you try and look for ways to be more efficient with the process,” Chancellor said. “We’ve had a lot of discussion about that and how we can bring a new record to fruition in a slightly different way.”
Carey added that recording new music is a “painstaking process” for Tool as the whole band, which also consists of vocalist Maynard James Keenan and guitarist Adam Jones, needs to like a particular song to move forward with it. This “pays off in the long run” because that way, the band doesn’t get tired of playing their songs during live shows.
One way Tool will try to get their music faster to fans without compromising their creative process is by releasing an extended play (EP) rather than an entire album. This is something that the band is strongly considering, according to Carey.
“We’re free agents now,” he explained. “We aren’t signed to a label anymore. We are free to do whatever we want.”
Tool topped the US Billboard 200 charts with Fear Inoculum, while the release received critical acclaim. The 15-minute long track “7empest” was recognized with a Grammy Award for Best Metal Performance.
